Fromm L, Overbeek P A
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Dev Genet. 1997;20(3):276-87. doi: 10.1002/(SICI)1520-6408(1997)20:3<276::AID-DVG10>3.0.CO;2-6.
Previous studies on cell cycle regulation in the ocular lens using transgenic mice have shown that inactivation of the retinoblastoma tumor suppressor protein (pRb) can cause postmitotic lens fiber cells to enter the cell cycle. However, when the p53 gene and protein are intact, inactivation of pRb in this terminally differentiated cell type results in cell death, rather than continued proliferation. Since bcl-2 has been shown to act as a cell death repressor, the ability of this gene to block p53-dependent apoptosis in lenses was examined. Transgenic mice were generated that overexpress bcl-2 in a lens-specific fashion. Surprisingly, overexpression of bcl-2 was sufficient to interfere with normal fiber cell differentiation, inducing cataracts, microphakia, vacuolization, fiber cell disorganization, and inhibition of fiber cell denucleation. The bcl-2 mice were mated to mice exhibiting lens-specific expression of the N-terminal region of simian virus 40 large T antigen (termed truncT). The resulting double transgenic mice showed a marked reduction in the truncT-induced fiber cell death. Apoptosis in the truncT mice could also be suppressed by crossing these mice into a p53-deficient background. Either overexpression of bcl-2 or loss of p53 in truncT mice resulted in proliferation of fiber cells around the cortex of the lens. These proliferating fiber cells continue to express beta- and gamma-crystallin proteins, which are normally only expressed following withdrawal from the cell cycle. The p53 protein is known to upregulate expression of certain target genes, including p21, a protein that can block cell cycle progression by inhibition of cyclin-dependent kinases. In order to assess whether bcl-2 interferes with the transcriptional activation activity of p53, transgenic lenses were assayed by in situ hybridization for levels of p21 expression. Lenses that expressed both truncT and bcl-2 showed elevated p21, implying that bcl-2 does not inhibit apoptosis by directly inhibiting p53, but instead may block a later step in the apoptosis pathway. In addition, overexpression of p21 is not sufficient to cause apoptosis. These experiments show that the lenses of transgenic mice represent a valuable in vivo setting for studies of both induction and inhibition of programmed cell death.
先前利用转基因小鼠对晶状体中细胞周期调控的研究表明,视网膜母细胞瘤肿瘤抑制蛋白(pRb)失活可导致有丝分裂后的晶状体纤维细胞进入细胞周期。然而,当p53基因和蛋白完整时,在这种终末分化细胞类型中pRb失活会导致细胞死亡,而非持续增殖。由于已证明bcl-2可作为细胞死亡抑制因子,因此研究了该基因在晶状体中阻断p53依赖性细胞凋亡的能力。构建了以晶状体特异性方式过表达bcl-2的转基因小鼠。令人惊讶的是,bcl-2过表达足以干扰正常的纤维细胞分化,引发白内障、小晶状体、空泡化、纤维细胞紊乱以及抑制纤维细胞核的去除。将bcl-2小鼠与表现出猿猴病毒40大T抗原N端区域晶状体特异性表达的小鼠(称为truncT)交配。所得的双转基因小鼠中,truncT诱导的纤维细胞死亡明显减少。将truncT小鼠与p53缺陷背景的小鼠杂交,也可抑制truncT小鼠中的细胞凋亡。truncT小鼠中bcl-2过表达或p53缺失均可导致晶状体皮质周围的纤维细胞增殖。这些增殖的纤维细胞持续表达β和γ晶状体蛋白,而这些蛋白通常仅在退出细胞周期后才表达。已知p53蛋白可上调某些靶基因的表达,包括p21,p21是一种可通过抑制细胞周期蛋白依赖性激酶来阻断细胞周期进程的蛋白。为了评估bcl-2是否干扰p53的转录激活活性,通过原位杂交检测转基因晶状体中p21的表达水平。同时表达truncT和bcl-2的晶状体显示p21水平升高,这意味着bcl-2并非通过直接抑制p53来抑制细胞凋亡,而是可能阻断细胞凋亡途径中的后续步骤。此外,p21过表达不足以引发细胞凋亡。这些实验表明,转基因小鼠的晶状体是研究程序性细胞死亡诱导和抑制的有价值的体内模型。